STX Group Launches Working Capital Solution to Accelerate Renewable Energy Transition

New SPV introduces innovative way to provide funding to environmental commodities markets Amsterdam, Dec. 05, 2023 (GLOBE NEWSWIRE) — AMSTERDAM (December 5, 2023) – STX Group, a leading environmental markets and climate solutions firm, today announces the launch of a working capital solution, specifically designed for environmental certificates. The launch comes as a response to the increased requirements […]

LeddarTech and Prospector Capital Corp. Announce Effectiveness of Registration Statement and December 13, 2023 Extraordinary General Meeting to Approve Business Combination

QUEBEC CITY, Dec. 04, 2023 (GLOBE NEWSWIRE) — LeddarTech Inc.® (“LeddarTech” or the “Company”), an automotive software company that provides patented disruptive AI-based low-level sensor fusion and perception software technology for ADAS and AD, and Prospector Capital Corp. (“Prospector”) (NASDAQ: PRSR, PRSRU, PRSRW), a publicly traded special-purpose acquisition company led by former Qualcomm President Derek […]

LeddarTech et Prospector Capital Corp. annoncent l’entrée en vigueur de la déclaration d’enregistrement et la tenue d’une assemblée générale extraordinaire le 13 décembre 2023 visant l’approbation du regroupement d’entreprises

QUÉBEC, 04 déc. 2023 (GLOBE NEWSWIRE) — LeddarTech Inc.® (« LeddarTech » ou l’« Entreprise »), une société de logiciels automobiles qui fournit des technologies logicielles de fusion bas niveau de capteurs et de perception reposant sur l’IA, innovatrices et brevetées pour systèmes avancés d’aide à la conduite (systèmes ADAS) et de conduite autonome (systèmes AD), et Prospector Capital […]

Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer

Expanded strategic and operational leadership positions Zenas for growth as obexelimab advances in late-stage clinical trials for multiple potential I&I indications WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) —  Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology (I&I) directed therapies, today announced the […]

Zenas BioPharma Fortalece a Liderança Executiva com a Nomeação de Jennifer Fox como Diretora de Negócios e Financeira, e de Tanya Fischer, MD, Ph.D. como Dirigente de P&D e Médica

Com a expansão dessa liderança estratégica e operacional, a Zenas se posiciona para o crescimento esperado com o avanço do voltadas para inflamações e imunologia nos ensaios clínicos em estágio avançado de várias indicações potenciais de I&I WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) — A Zenas BioPharma, uma empresa biofarmacêutica global comprometida em se […]

EMAIL NEWSLETTER

Subscribe to receive inspiration, ideas, and news in your inbox